Literature DB >> 18823397

The classification and diagnosis of erythrocytosis.

M F McMullin1.   

Abstract

An absolute erythrocytosis is present when the red cell mass is raised and the haematocrit is elevated above prescribed limits. Causes of an absolute erythrocytosis can be primary where there is an intrinsic problem in the bone marrow and secondary where there an event outside the bone marrow driving erythropoiesis. This can further be divided into congenital and acquired causes. There remain an unexplained group idiopathic erythrocytosis. Investigation commencing with thorough history taking and examination and then investigation depending on initial features is required. Clear simple criteria for polycythaemia vera are now defined. Those who do not fulfil these criteria require further investigation depending on the clinical scenario and initial results. The erythropoietin level provides some guidance as to the direction in which to proceed and the order and extent of investigation necessary in an individual patient. It should thus be possible to make an accurate diagnosis in the majority of patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823397     DOI: 10.1111/j.1751-553X.2008.01102.x

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  31 in total

1.  IgG4-related disease associated with renal microaneurysms and polycythaemia.

Authors:  François-Xavier Danlos; Fadela Daoued-Keffi; Julien Rohmer; Guillaume Cluzel; Estelle Blanc-Autran; Hélène François; Thierry Lazure; Raphaele Seror; Xavier Mariette
Journal:  Rheumatology (Oxford)       Date:  2015-10-13       Impact factor: 7.580

2.  High hematocrit as a risk factor for venous thrombosis. Cause or innocent bystander?

Authors:  Anja J M Schreijer; Pieter H Reitsma; Suzanne C Cannegieter
Journal:  Haematologica       Date:  2010-02       Impact factor: 9.941

3.  Erythrocytosis in the general population: clinical characteristics and association with clonal hematopoiesis.

Authors:  Hanneke J C M Wouters; René Mulder; Isabelle A van Zeventer; Jan Jacob Schuringa; Melanie M van der Klauw; Pim van der Harst; Arjan Diepstra; André B Mulder; Gerwin Huls
Journal:  Blood Adv       Date:  2020-12-22

Review 4.  Rethinking the diagnostic criteria of polycythemia vera.

Authors:  T Barbui; J Thiele; A M Vannucchi; A Tefferi
Journal:  Leukemia       Date:  2013-12-19       Impact factor: 11.528

5.  Thrombocytopenia and erythrocytosis in mice with a mutation in the gene encoding the hemoglobin β minor chain.

Authors:  Maria Kauppi; Adrienne A Hilton; Donald Metcalf; Ashley P Ng; Craig D Hyland; Janelle E Collinge; Benjamin T Kile; Douglas J Hilton; Warren S Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

Review 6.  Hypoxia-inducible factors link iron homeostasis and erythropoiesis.

Authors:  Yatrik M Shah; Liwei Xie
Journal:  Gastroenterology       Date:  2013-12-31       Impact factor: 22.682

7.  Erythrocytosis associated with a novel missense mutation in the HIF2A gene.

Authors:  Richard van Wijk; Scott Sutherland; Annet C W Van Wesel; Eric G Huizinga; Melanie J Percy; Marc Bierings; Frank S Lee
Journal:  Haematologica       Date:  2009-12-08       Impact factor: 9.941

8.  Hemoglobin and hip fracture risk in older non-Hispanic white adults.

Authors:  A C Looker
Journal:  Osteoporos Int       Date:  2014-06-18       Impact factor: 4.507

9.  Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations.

Authors:  Carme Camps; Nayia Petousi; Celeste Bento; Holger Cario; Richard R Copley; Mary Frances McMullin; Richard van Wijk; Peter J Ratcliffe; Peter A Robbins; Jenny C Taylor
Journal:  Haematologica       Date:  2016-09-20       Impact factor: 9.941

10.  Dissecting Primary Erythrocytosis Among Polycythemia Patients Referred to an Indian Armed Forces Hospital.

Authors:  Harshit Khurana; Praveen Lakshman; Kishore Kumar; Arihant Jain
Journal:  Indian J Hematol Blood Transfus       Date:  2019-07-08       Impact factor: 0.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.